Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD) (MSOT_IBD)
Primary Purpose
Crohn's Disease, Ulcerative Colitis, IBD
Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Multispectral Optoacoustic Tomography (MSOT)
Sponsored by
About this trial
This is an interventional diagnostic trial for Crohn's Disease focused on measuring Photoacoustics, Optoacoustics, Ultrasound
Eligibility Criteria
Inclusion Criteria:
- Histological verified Crohn's disease or ulcerative colitis
- Age > 18 years
Exclusion Criteria:
- Age < 18 years
- Mental retardation of the patient with restriction of general judgment and awareness
Sites / Locations
- Medical Department 1, University of Erlangen-Nürnberg
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Multispectral Optoacoustic Tomography
Arm Description
Multispectral Optoacoustic Tomography (MSOT) for the evaluation of disease activity in inflammatory bowel diseases (IBD)
Outcomes
Primary Outcome Measures
Correlation of MSOT-data with clinical activity scores of IBD
Correlation of MSOT-data with sonographic parameters
Secondary Outcome Measures
Full Information
NCT ID
NCT02622139
First Posted
December 2, 2015
Last Updated
December 5, 2019
Sponsor
University of Erlangen-Nürnberg Medical School
Collaborators
iThera Medical GmbH
1. Study Identification
Unique Protocol Identification Number
NCT02622139
Brief Title
Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD)
Acronym
MSOT_IBD
Official Title
Monocentric, Prospective Interventional Study to Assess the Degree of Disease Activity With a Multispectral Optoacoustic Tomography (MSOT) Handheld Scanner in Patients With Crohn's Disease or Ulcerative Colitis
Study Type
Interventional
2. Study Status
Record Verification Date
December 2019
Overall Recruitment Status
Completed
Study Start Date
November 2015 (undefined)
Primary Completion Date
October 2017 (Actual)
Study Completion Date
December 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Erlangen-Nürnberg Medical School
Collaborators
iThera Medical GmbH
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Monocentric, prospective interventional study to assess the degree of disease activity with a multispectral optoacoustic tomography (MSOT) handheld scanner in patients with Crohn's disease or ulcerative colitis.
Detailed Description
The proposed study is designed as a pilot study to evaluate the usefulness of MSOT for the evaluation of disease activity in IBD patients. As current methods for the evaluation of intestinal inflammation in IBD have relevant restrictions, new, non-invasive, quantitative, and accurate modalities are urgently needed. In comparison to other techniques, MSOT provides relevant advantages such as non-invasive imaging, high spatial resolution (this is of special importance for the evaluation of the intestine, which can be only a few millimeters thick), and highly sensitive detection of specific molecules such as total hemoglobin or oxy- /deoxygenated hemoglobin. These advantages suggest MSOT as an outstanding technique for evaluating disease activity in IBD.
The proposed study incorporates nearly no risk for participating patients and might provide relevant data for more a more in depth analysis of MSOT for IBD diagnosis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Crohn's Disease, Ulcerative Colitis, IBD
Keywords
Photoacoustics, Optoacoustics, Ultrasound
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
344 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Multispectral Optoacoustic Tomography
Arm Type
Experimental
Arm Description
Multispectral Optoacoustic Tomography (MSOT) for the evaluation of disease activity in inflammatory bowel diseases (IBD)
Intervention Type
Device
Intervention Name(s)
Multispectral Optoacoustic Tomography (MSOT)
Intervention Description
MSOT for the evaluation of disease activity in IBD patients
Primary Outcome Measure Information:
Title
Correlation of MSOT-data with clinical activity scores of IBD
Time Frame
12 month
Title
Correlation of MSOT-data with sonographic parameters
Time Frame
12 month
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Histological verified Crohn's disease or ulcerative colitis
Age > 18 years
Exclusion Criteria:
Age < 18 years
Mental retardation of the patient with restriction of general judgment and awareness
Facility Information:
Facility Name
Medical Department 1, University of Erlangen-Nürnberg
City
Erlangen
State/Province
Bavaria
ZIP/Postal Code
91054
Country
Germany
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
28355498
Citation
Knieling F, Neufert C, Hartmann A, Claussen J, Urich A, Egger C, Vetter M, Fischer S, Pfeifer L, Hagel A, Kielisch C, Gortz RS, Wildner D, Engel M, Rother J, Uter W, Siebler J, Atreya R, Rascher W, Strobel D, Neurath MF, Waldner MJ. Multispectral Optoacoustic Tomography for Assessment of Crohn's Disease Activity. N Engl J Med. 2017 Mar 30;376(13):1292-1294. doi: 10.1056/NEJMc1612455. No abstract available.
Results Reference
result
PubMed Identifier
27269244
Citation
Waldner MJ, Knieling F, Egger C, Morscher S, Claussen J, Vetter M, Kielisch C, Fischer S, Pfeifer L, Hagel A, Goertz RS, Wildner D, Atreya R, Strobel D, Neurath MF. Multispectral Optoacoustic Tomography in Crohn's Disease: Noninvasive Imaging of Disease Activity. Gastroenterology. 2016 Aug;151(2):238-40. doi: 10.1053/j.gastro.2016.05.047. Epub 2016 Jun 3. No abstract available.
Results Reference
result
Learn more about this trial
Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD)
We'll reach out to this number within 24 hrs